Digestive & Intestinal Remedies (Pharmacies) - Saudi Arabia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$57.31m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.08%, resulting in a market volume of US$57.54m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$1.53 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Saudi Arabia is experiencing significant growth and development.

Customer preferences: Customers in Saudi Arabia are increasingly seeking digestive and intestinal remedies from pharmacies. This can be attributed to several factors, including the growing awareness of digestive health issues and the convenience of purchasing remedies from pharmacies. Additionally, customers in Saudi Arabia tend to trust and rely on the advice of pharmacists, making pharmacies a preferred destination for digestive and intestinal remedies.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Saudi Arabia is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the potential side effects of traditional pharmaceutical products and are opting for natural alternatives. This trend is driven by a growing interest in holistic health and wellness, as well as a preference for products that are perceived as more sustainable and environmentally friendly. Another trend in the market is the rise of online sales of digestive and intestinal remedies. With the increasing popularity of e-commerce in Saudi Arabia, customers are now able to conveniently purchase these products online and have them delivered to their doorstep. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wide range of products from different brands.

Local special circumstances: Saudi Arabia has a high prevalence of digestive health issues, such as indigestion, acid reflux, and irritable bowel syndrome. This can be attributed to factors such as dietary habits, stress, and sedentary lifestyles. As a result, there is a strong demand for digestive and intestinal remedies in the market. The local special circumstances in Saudi Arabia also include cultural and religious factors, which influence dietary preferences and may contribute to digestive health issues.

Underlying macroeconomic factors: The growth of the Digestive & Intestinal Remedies market in Saudi Arabia is also influenced by several macroeconomic factors. The country has a rapidly growing population, which provides a large customer base for these products. Additionally, Saudi Arabia has a high per capita income and a strong healthcare system, which enables customers to afford and access these remedies. Furthermore, the government's focus on healthcare and wellness initiatives, as well as the increasing investment in the pharmaceutical sector, contribute to the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Saudi Arabia is developing due to customer preferences for convenient access to remedies, the increasing demand for natural and herbal products, the rise of online sales, the high prevalence of digestive health issues, and the underlying macroeconomic factors such as population growth, per capita income, and government initiatives.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.